Genocea Biosciences Inc (OTCPK:GGNNQ)
$ 0.0005 0 (0%) Market Cap: - Enterprise Value: - PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Genocea Biosciences, Inc. - Special Call Transcript

Nov 09, 2020 / 01:30PM GMT
Operator

Greetings, and welcome to the investor call hosted by Genocea Biosciences. (Operator Instructions). As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Chip Clark, Chief Executive Officer of Genocea. Thank you, Chip. You may begin.

William D. Clark
Genocea Biosciences, Inc. - President, CEO & Director

Thank you, and good morning, everyone. As our 4 city posters go live this morning, we're pleased to provide you an in-depth perspective on 2 in particular, which focus on the GEN-009 Part B immunogenicity and clinical responses. I am joined today by Tom Davis, our Chief Medical Officer; Jessica Flechtner, our Chief Scientific Officer; and Diantha Duvall, our CFO. Please be advised that we may be making forward-looking statements. Now let me briefly introduce to you the 3 points that we'll be making today. First, GEN-009 appears to be working. We reported on an early signal months ago and now with more patients and with longer follow-up, we think the signal is clearer. Second, targets do matter. Here is that ATLAS

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot